Evidence map›Paper›PMID 29296823›Full record

ArticleBlood advances2017

Mature murine megakaryocytes present antigen-MHC class I molecules to T cells and transfer them to platelets.

Anne Zufferey, Edwin R Speck, Kellie R Machlus, Rukhsana Aslam, Li Guo, Mark J McVey, Michael Kim, Rick Kapur, Eric Boilard, Joseph E Italiano and 1 more

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 128 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Immunological face of megakaryocytes.Frontiers of medicine · 2024
    Review
  20. Versatility of megakaryocytes in homeostasis and disease.Blood science (Baltimore, Md.) · 2024
    Review

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Anne ZuffereyToronto Platelet Immunobiology Group, Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada.
Edwin R SpeckToronto Platelet Immunobiology Group, Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada.
Kellie R MachlusDivision of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Rukhsana AslamToronto Platelet Immunobiology Group, Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada.
Li GuoToronto Platelet Immunobiology Group, Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada.
Mark J McVeyToronto Platelet Immunobiology Group, Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada.
Michael KimToronto Platelet Immunobiology Group, Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada.
Rick KapurToronto Platelet Immunobiology Group, Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada.
Eric BoilardCentre de Recherche du Centre Hospitalier Universitaire de Québec, Département de Microbiologie et Immunologie, Faculté de Médecine, Université Laval, Québec, QC, Canada.
Joseph E ItalianoDivision of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
John W SempleToronto Platelet Immunobiology Group, Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada.
St. Michael's Hospital · CAHarvard University · USLund University · SEUniversité Laval · CA

Funding

Cytoskeletal Mechanisms of Platelet FormationR01HL068130 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ITALIANO, JOSEPH E · 2001 to 2021
$8.1M
Molecular mechanisms of megakaryocyte differentiation and maturation during inflammationK01DK111515 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI MACHLUS, KELLIE RAE · 2016 to 2020
$793k
Identification of molecular pathways that initiate proplatelet formationF32HL118865 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MACHLUS, KELLIE RAE · 2013 to 2016
$132k
NHLBI NIH HHS F32 HL118865NIDDK NIH HHS K01 DK111515
6 · The paper itself

Abstract

Megakaryocytes (MKs) are bone marrow-derived cells that are primarily responsible for generating platelets for the maintenance of hemostasis. Although MK can variably express major histocompatibility complex (MHC) class I and II molecules during their differentiation, little is known whether they can elicit nonhemostatic immune functions such as T-cell activation. Here, we demonstrate that mature CD34

Identifiers

PMID29296823
PMCPMC5728336
OpenAlexW2765241801

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.